RINVOQ is now approved as the first and only oral JAK inhibitor for adults with active non-radiographic axial spondyloarthritis (nr-axSpA) RINVOQ is the first and only JAK inhibitor approved for both active ankylosing spondylitis (AS) and nr-axSpA1-3 In a clinical study, RINVOQ delivered…
Related Posts
CAVALIER RESORT’S NEWEST EMBASSY SUITES HOTEL GRAND OPENING SLATED FOR FEBRUARY 2023
VIRGINIA BEACH, Va., Sept. 14, 2022 /PRNewswire/ — Gold Key|PHR and the Cavalier Resort have confirmed its third and final luxury resort hotel: The Embassy Suites Resort Virginia Beach Oceanfront Hotel, is nearing completion. The new hotel will be an award-winner in its own right and…
Universal Technical Institute Opens 2nd New Campus in 2022, Bringing Industry-Aligned Automotive, Diesel and Welding Technology Training to South Florida
New Miramar campus part of company’s strategic growth and expansion initiatives MIRAMAR, Fla., Aug. 9, 2022 /PRNewswire/ — Universal Technical Institute (NYSE: UTI) is pleased to announce the opening of its new Miramar, Fla. campus, which will serve the South Florida region and mark a…
Air PREMIA Airlines goes live with IBS Software’s iCargo to transform its Global Cargo Operations
SEOUL, South Korea, July 6, 2022 /PRNewswire/ — Air PREMIA Airlines, a recently established start-up from South Korea with business operations across the regional and international circuits, has gone live with IBS Software’s iCargo Management solution for its air cargo business. The mid…